Is a methodology available that accurately measures the cost of an FDG-PET study?

Eur J Nucl Med Mol Imaging. 2007 May;34(5):625-627. doi: 10.1007/s00259-006-0308-y. Epub 2006 Dec 8.

Authors

Bruno Krug¹, Anne Sophie Pirson², Ralph Crott³, Thierry Vander Borght²

Affiliations

¹ Nuclear Medicine Department, Université Catholique de Louvain, 1 Dr Thérasse, 5530, Yvoir, Belgium. bruno.krug@imre.ucl.ac.be.
² Nuclear Medicine Department, Université Catholique de Louvain, 1 Dr Thérasse, 5530, Yvoir, Belgium.
³ Belgian Health Care Knowledge Center, Brussels, Belgium.

PMID: 17160411
DOI: 10.1007/s00259-006-0308-y

No abstract available

Publication types

Editorial

MeSH terms

Cost-Benefit Analysis
Costs and Cost Analysis
Diagnostic Imaging / economics
Economics, Medical
Fluorodeoxyglucose F18*
Humans
Positron-Emission Tomography / economics*
Positron-Emission Tomography / methods*
Radiopharmaceuticals*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18